Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Clinical Relevance of the NATALEE Study: Application of the NATALEE Criteria to a Real-World Cohort from Two Large German Breast Cancer Centers.
Schäffler H, Mergel F, Pfister K, Lukac S, Fink A, Veselinovic K, Rack B, Fink V, Leinert E, Dimpfl M, Englisch A, Tegeler CM, Seller A, Grischke EM, Hahn M, Volmer LL, Engler T, Frevert ML, Taran FA, Janni W, Brucker SY, Hartkopf AD, Dannehl D. Schäffler H, et al. Int J Mol Sci. 2023 Nov 15;24(22):16366. doi: 10.3390/ijms242216366. Int J Mol Sci. 2023. PMID: 38003555 Free PMC article.
Which Patients Do We Need to Test for BRCA1/2 Mutation? Feasibility of Adjuvant Olaparib Treatment in Early Breast Cancer-Real-World Data from Two Large German Breast Centers.
Dannehl D, Engler T, Volmer LL, Tegeler CM, Fusshoeller J, Gabrysch E, Eissler K, Seller A, Grischke EM, Hahn M, Gruber I, Schochter F, Pfister K, Veselinovic K, Leinert E, Rack B, Fink V, Janni W, Brucker SY, Hartkopf AD, Schäffler H. Dannehl D, et al. Among authors: schaffler h. Cancers (Basel). 2023 Jul 28;15(15):3847. doi: 10.3390/cancers15153847. Cancers (Basel). 2023. PMID: 37568663 Free PMC article.
Three-dimensional model for improvement of endometriosis care (3D-E).
Lukac S, Hancke K, Janni W, Pfister K, Schäffler H, Schmid M, Ebner F, Kloss T, Dayan D. Lukac S, et al. Among authors: schaffler h. Int J Gynaecol Obstet. 2024 May;165(2):416-423. doi: 10.1002/ijgo.15165. Epub 2023 Oct 5. Int J Gynaecol Obstet. 2024. PMID: 37795648 Review.
Feasibility of targeted therapies in the adjuvant setting of early breast cancer in men: real-world data from a population-based registry.
Frevert ML, Dannehl D, Jansen L, Hermann S, Schäffler H, Huwer S, Janni W, Juhasz-Böss I, Hartkopf AD, Taran FA. Frevert ML, et al. Among authors: schaffler h. Arch Gynecol Obstet. 2024 Jun;309(6):2811-2819. doi: 10.1007/s00404-024-07405-5. Epub 2024 Mar 12. Arch Gynecol Obstet. 2024. PMID: 38472501 Free PMC article.
The efficacy of sacituzumab govitecan and trastuzumab deruxtecan on stable and active brain metastases in metastatic breast cancer patients-a multicenter real-world analysis.
Dannehl D, Jakob D, Mergel F, Estler A, Engler T, Volmer L, Frevert ML, Matovina S, Englisch A, Tegeler CM, Rohner A, Seller A, Hahn M, Pfister K, Fink A, Popp I, Lorenz S, Tabatabai G, Juhasz-Böss I, Janni W, Brucker S, Taran FA, Hartkopf A, Schäffler H. Dannehl D, et al. Among authors: schaffler h. ESMO Open. 2024 May;9(5):102995. doi: 10.1016/j.esmoop.2024.102995. Epub 2024 Apr 17. ESMO Open. 2024. PMID: 38636292 Free PMC article.
Novel Antibody-Drug-Conjugates in Routine Clinical Practice for the Treatment of Metastatic Breast Cancer: Adherence, Efficacy and Tolerability - Real-World Data from German Breast Centers.
Schäffler H, Jakob D, Huesmann S, Pfister K, Veselinovic K, Schochter F, Leinert E, Fink V, Rack B, Englisch A, Volmer LL, Engler T, Frevert ML, Juhasz-Böss I, Brucker S, Heublein S, Janni W, Taran FA, Hartkopf A, Dannehl D. Schäffler H, et al. Geburtshilfe Frauenheilkd. 2024 Sep 2;84(9):855-865. doi: 10.1055/a-2375-5194. eCollection 2024 Sep. Geburtshilfe Frauenheilkd. 2024. PMID: 39229630 Free PMC article.
42 results